(Q71983561)
Statements
A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation (English)
T van Gelder
R Zietse
A H Mulder
J N Yzermans
C J Hesse
L M Vaessen